Evaluation and management of systemic lupus erythematosus and rheumatoid arthritis during pregnancy

Medha Barbhaiya, Bonnie L. Bermas

Research output: Contribution to journalReview article

24 Citations (Scopus)

Abstract

Women of childbearing age are at risk for developing systemic rheumatic diseases. Pregnancy can be challenging to manage in patients with rheumatic diseases for a variety of reasons including the impact of physiological and immunological changes of pregnancy on underlying disease activity, the varied presentation of rheumatic disease during pregnancy, and the limited treatment options. Previously, patients with rheumatic disease were often advised against pregnancy due to concerns of increased maternal and fetal morbidity and mortality. However, recent advancements in the understanding of the interaction between pregnancy and rheumatic disease have changed how we counsel patients. Patients with rheumatic disease can have successful pregnancy outcomes, particularly when a collaborative approach between the rheumatologist and obstetrician is applied. This review aims to discuss the effect of pregnancy on patients with the most common rheumatic diseases, the effect of these diseases on the pregnancy itself, and the management of these patients during pregnancy.

Original languageEnglish (US)
Pages (from-to)225-235
Number of pages11
JournalClinical Immunology
Volume149
Issue number2
DOIs
StatePublished - Nov 1 2013

Fingerprint

Systemic Lupus Erythematosus
Rheumatic Diseases
Rheumatoid Arthritis
Pregnancy
Fetal Mortality
Pregnancy Outcome
Mothers
Morbidity

Keywords

  • Fertility
  • Pregnancy
  • Rheumatoid arthritis
  • Systemic lupus erythematosus
  • Treatment

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Evaluation and management of systemic lupus erythematosus and rheumatoid arthritis during pregnancy. / Barbhaiya, Medha; Bermas, Bonnie L.

In: Clinical Immunology, Vol. 149, No. 2, 01.11.2013, p. 225-235.

Research output: Contribution to journalReview article

@article{1e08e9fc1f044ab5883ad31a07bbebf8,
title = "Evaluation and management of systemic lupus erythematosus and rheumatoid arthritis during pregnancy",
abstract = "Women of childbearing age are at risk for developing systemic rheumatic diseases. Pregnancy can be challenging to manage in patients with rheumatic diseases for a variety of reasons including the impact of physiological and immunological changes of pregnancy on underlying disease activity, the varied presentation of rheumatic disease during pregnancy, and the limited treatment options. Previously, patients with rheumatic disease were often advised against pregnancy due to concerns of increased maternal and fetal morbidity and mortality. However, recent advancements in the understanding of the interaction between pregnancy and rheumatic disease have changed how we counsel patients. Patients with rheumatic disease can have successful pregnancy outcomes, particularly when a collaborative approach between the rheumatologist and obstetrician is applied. This review aims to discuss the effect of pregnancy on patients with the most common rheumatic diseases, the effect of these diseases on the pregnancy itself, and the management of these patients during pregnancy.",
keywords = "Fertility, Pregnancy, Rheumatoid arthritis, Systemic lupus erythematosus, Treatment",
author = "Medha Barbhaiya and Bermas, {Bonnie L.}",
year = "2013",
month = "11",
day = "1",
doi = "10.1016/j.clim.2013.05.006",
language = "English (US)",
volume = "149",
pages = "225--235",
journal = "Clinical Immunology",
issn = "1521-6616",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Evaluation and management of systemic lupus erythematosus and rheumatoid arthritis during pregnancy

AU - Barbhaiya, Medha

AU - Bermas, Bonnie L.

PY - 2013/11/1

Y1 - 2013/11/1

N2 - Women of childbearing age are at risk for developing systemic rheumatic diseases. Pregnancy can be challenging to manage in patients with rheumatic diseases for a variety of reasons including the impact of physiological and immunological changes of pregnancy on underlying disease activity, the varied presentation of rheumatic disease during pregnancy, and the limited treatment options. Previously, patients with rheumatic disease were often advised against pregnancy due to concerns of increased maternal and fetal morbidity and mortality. However, recent advancements in the understanding of the interaction between pregnancy and rheumatic disease have changed how we counsel patients. Patients with rheumatic disease can have successful pregnancy outcomes, particularly when a collaborative approach between the rheumatologist and obstetrician is applied. This review aims to discuss the effect of pregnancy on patients with the most common rheumatic diseases, the effect of these diseases on the pregnancy itself, and the management of these patients during pregnancy.

AB - Women of childbearing age are at risk for developing systemic rheumatic diseases. Pregnancy can be challenging to manage in patients with rheumatic diseases for a variety of reasons including the impact of physiological and immunological changes of pregnancy on underlying disease activity, the varied presentation of rheumatic disease during pregnancy, and the limited treatment options. Previously, patients with rheumatic disease were often advised against pregnancy due to concerns of increased maternal and fetal morbidity and mortality. However, recent advancements in the understanding of the interaction between pregnancy and rheumatic disease have changed how we counsel patients. Patients with rheumatic disease can have successful pregnancy outcomes, particularly when a collaborative approach between the rheumatologist and obstetrician is applied. This review aims to discuss the effect of pregnancy on patients with the most common rheumatic diseases, the effect of these diseases on the pregnancy itself, and the management of these patients during pregnancy.

KW - Fertility

KW - Pregnancy

KW - Rheumatoid arthritis

KW - Systemic lupus erythematosus

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=84886084693&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886084693&partnerID=8YFLogxK

U2 - 10.1016/j.clim.2013.05.006

DO - 10.1016/j.clim.2013.05.006

M3 - Review article

C2 - 23773975

AN - SCOPUS:84886084693

VL - 149

SP - 225

EP - 235

JO - Clinical Immunology

JF - Clinical Immunology

SN - 1521-6616

IS - 2

ER -